跳至主要内容
临床试验/NCT03414840
NCT03414840Unknown不适用

Assessment of Change in Atherosclerotic Plaque by Serial CCTA

Yonsei University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2018年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
400
试验地点
1
主要终点
Difference in percent change of total atheroma volume assessed by CCTA between statin-taking and statin-naïve group

研究概览

简要总结

Assessment of Change in AtheROSclerotic Plaque by Serial CCTA (ACROSS) is designed as a prospective observational study which aim is to demonstrate the effect of statins on coronary atherosclerosis, assessed by quantitative analysis of CCTA.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who underwent clinically indicated CCTA (index CCTA)
  • Mild to moderate stenosis (25-69%) on CCTA
  • ≥1 clinical risk factors (Smoking, HTN, HDL<40, Premature FHx, M ≥45, F ≥55) for CAD

排除标准

  • Acute coronary syndrome (unstable angina or MI)
  • Positive (not equivocal) stress test
  • Contraindications to statin

结局指标

主要结局

Difference in percent change of total atheroma volume assessed by CCTA between statin-taking and statin-naïve group

时间窗: 24 months

Patients indicated with statin therapy according to current guideline will receive atorvastatin.

次要结局

  • Change of total atheroma volume at 24 months compared with baseline total atheroma volume(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyuk-Jae Chang

Professor

Yonsei University

研究点 (1)

Loading locations...

相似试验